Loading...
XNSE
KAYA
Market cap67mUSD
Nov 12, Last price  
420.95INR
Name

Kaya Ltd

Chart & Performance

D1W1MN
XNSE:KAYA chart
P/E
P/S
2.87
EPS
Div Yield, %
Shrs. gr., 5y
2.00%
Rev. gr., 5y
-4.14%
Revenues
2.22b
+2.44%
1,051,200,0001,296,300,0001,433,300,0002,902,700,0003,322,706,0003,698,998,0004,102,488,0003,998,464,0004,203,780,0003,926,528,0002,748,210,0003,239,230,0003,767,334,0004,042,504,0002,171,683,0002,224,755,000
Net income
-962m
L+112.20%
-364,500,000-2,800,000-304,400,000-317,400,000317,833,00087,977,000-8,207,000-211,343,000-159,641,000-544,235,000-380,137,000-688,374,000-1,164,675,000-1,292,152,000-453,216,000-961,731,000
CFO
-105m
L-58.43%
144,300,000240,500,000340,300,000918,000,000292,451,00047,434,000-59,690,000-115,248,000217,464,000472,612,000316,113,000298,894,000627,779,000387,926,000-253,687,000-105,457,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kaya Limited manages and operates a network of specialized clinics focused on dermatological and trichological well-being. The company delivers a wide spectrum of treatments addressing issues such as age-related skin concerns, pigmentation irregularities, acne and scar management, permanent laser hair reduction, hair loss prevention, surgical hair restoration, and solutions for dandruff or under-nourished hair. Additionally, it provides various aesthetic improvement services. Beyond its clinical offerings, Kaya also manufactures and distributes a diverse collection of hair and skin care products tailored for both men and women. These products are retailed through Kaya's own brand stores, numerous online platforms, third-party vendors, and its dedicated e-commerce site, shop.kaya.in. The company's operational footprint encompasses 71 clinics throughout India and an additional 23 establishments situated in the Middle East. Established in 2002, Kaya Limited is headquartered in Mumbai, India.
IPO date
Aug 14, 2015
Employees
Domiciled in
IN
Incorporated in
IN

Valuation

Title
INR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT